Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR

NCT06763744 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

3000

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
High Bleeding Risk

Interventions

DRUG: P2Y12 antagonist monotherapy
DRUG: clopidogrel + aspirin

Sponsor

Samsung Medical Center